CRAB has chameleon-like tendencies that allow it to absorb material from other organisms, and that allows it to ward off most antibiotics. It’s a Superbug.
Carbapenem-resistant Acinetobacter baumannii (CRAB) is not much seen in the United States now, but it has begun to emerge as a deadly pathogen where it does strike, with a 55% mortality rate and an ability to resist most antibiotics thrown its way. Investigators with the Utah Department of Health (UDOH) wanted to study what should be the best response when CRAB emerged at a skilled nursing facility in that state in February 2018. Investigators argue that their findings, published in a pre-print study in the American Journal of Infection Control, suggest that the kind of infection control and prevention methods seen in intensive care units (ICUs) should also be used at skilled nursing facilities that have a ventilator (what the authors abbreviate as vSNF). Such vSNFs can attract highly resistant pathogens.
“Containment in this resource-restrained setting requires an aggressive multi-faceted infection control approach that will address the multiple gaps that have contributed to the outbreak,” the study states. “Resources should be prioritized to enhance basic infection control practices such as: hand hygiene and PPE [personal protective equipment] use; surveillance; environmental cleaning, and communication between providers. An understanding of patient transfer patterns and increased surveillance and reporting of CRAB throughout the United States, and a regional approach focusing on inter-facility connections would improve regional containment efforts.”
A patient identified as Patient 1 was found to have CRAB posthumously. Four other patients at the facility were also afflicted with the disease. An investigation was launched by the UDOH and the US Centers for Disease Control and Prevention (CDC).
“Of the 47 patients screened, OXA-23-producing CRAB were detected in 10 patients (21%), with 7 patients (15%) having been transferred from out-of-state facilities,” the study states. “Of patients who screened positive, 60% did not exhibit any signs or symptoms of active infection by chart review. A total of 38 environmental samples were collected and CRAB was recovered from 37% of those samples. Whole genome sequencing analyses of patient and environmental isolates suggested repeated CRAB introduction into the facility and highlighted the role of shared equipment in transmission.”
Investigators note that CRAB can survive for up to six months in dry environments and that makes them very difficult to kill in healthcare settings. Furthermore, CRAB has chameleon-like tendencies because it can absorb material from other organisms, and that allows it to ward off most antibiotics. It’s a Superbug.
“Acinetobacter baumannii can cause infections in the blood, urinary tract, and lungs (pneumonia), or in wounds in other parts of the body,” says the CDC. “It can also ‘colonize’ or live in a patient without causing infections or symptoms, especially in respiratory secretions (sputum) or open wounds.”
Which is what happened at the Utah facility, which investigators found out after collecting sputum, oropharyngeal, wound and skin samples from the groin and axilla. Meanwhile, they also investigated the environment, focusing on high-touch surfaces such as nursing carts, physical therapy equipment, vital signs monitoring equipment, ventilators, bed rails, and respiratory therapy equipment.
“Immediate recommendations included: training and auditing of hand hygiene and PPE [personal protective equipment] use; limiting access to the high-acuity unit; and improved cleaning of high-risk areas and shared patient equipment,” the study states.
Investigators take into account the intrinsic differences between ICUs and vSNFs, writing that “because the patient population in the high-acuity vSNF setting is similar to those seen in ICUs, containment strategies should be modeled after infection control practices in ICU settings, while also balancing patient quality of life and available resources.”
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.